Goat anti-IRF2 Antibody |
| Principle Name | IRF2 |
| Official Symbol | IRF2 |
| All Name and Symbols | IRF2; interferon regulatory factor 2; DKFZp686F0244; IRF-2 |
| Accession Number(s) | NP_002190.2 |
| Peptide Sequence | KTSDITQARVKSC, is from C Terminus |
| Human Gene ID(s) | 3660 |
| Non-Human GeneID(s) | 16363 (mouse); |
| Important Comments | |
| Purification | Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Supplied As | lyophilized powder of 50ug or 100ug IgG; Reconsititute IgG with 100ul or 200ul sterile DI Water and final product will be formulated as 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20°C. Minimize freezing and thawing. |
| Applications | Pep ELISA, WB |
| Tested Species | Human, Mouse |
| Peptide ELISA | antibody detection limit dilution 1 to 2000. |
| Western Blot | Approx 48kDa band observed in lysates of cell line Jurkat (calculated MW of 39.3kDa according to NP_002190.2). The observed molecular weight corresponds to earlier findings in literature with different antibodies (Li et al, Invest Ophthalmo |
| Reference(s) | Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M, Taniguchi T. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science. 1993 Feb 12;259(5097) |
